Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Drug Enforcement Agency (“DEA”). The federal government and most of the states in the U.S.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

SEPTEMBER 23, 2021

Tracking recent data from within the last year (following the publication of the DEA Interim Final Rule which added confusion to the delta-8 legality question), more than a dozen hospital or emergency room visits and hundreds of calls to poison control were reported. Delta-8 THC products should be kept out of the reach of children and pets.

THC 52

THC Concentrates Pets DEA 52

Cannabis Law Report

JUNE 15, 2021

Reinvests funds to support programs that work on expanding access to substance use treatment, support harm reduction services, and reduce the criminalization of individuals who use drugs by supporting the development or expansion of pre-arrest diversion programs.

Decriminalization 78

Decriminalization Policy Research and Development Data 78

SpeedWeed

MARCH 18, 2021

Preliminary results from a long-awaited study indicate that cannabis appears to be a safe and well-tolerated treatment for patients managing post-traumatic stress disorder (PTSD), although researchers did not find strong signals of effectiveness. Wasn’t the DEA going to let others grow research-grade cannabis? It tested at only 9% THC.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Cannabis Law Report

APRIL 14, 2022

Similar issues arise under state and federal employee safety and worker Right-to-Know laws, as employees must be educated on the chemicals present and proper handling and risk management procedures. pursuant to Drug Enforcement Agency (DEA) or state-level programs).

Environment 52

Environment Agriculture Compliance Compliance 52

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi. Program between St.

Research and Development 117

Research and Development Education Agriculture Patients 117

PrestoDoctor

JANUARY 14, 2020

They are responsible for giving you information about the treatment and proper use. government Tribal identification card approved by the Oklahoma Department of Public Safety for identification. You may also submit it at a later date by accessing your online account. Who Monitors This Program in Oklahoma?

Marijuana 52

Marijuana Patients Conditions Programs 52

PrestoDoctor

JANUARY 14, 2020

They are responsible for giving you information about the treatment and proper use. government Tribal identification card approved by the Oklahoma Department of Public Safety for identification. You may also submit it at a later date by accessing your online account. Who Monitors This Program in Oklahoma?

Marijuana 52

Marijuana Patients Conditions Programs 52

Canna Law Blog

NOVEMBER 6, 2021

To acknowledge its impressive safety record and potential for treating depression more effectively than existing therapies, the Food and Drug Administration designated psilocybin a breakthrough therapy in 2018 and 2019 for treating drug-resistant depression and major depressive disorder. But only if it is made affordable and accessible.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Canna Law Blog

MARCH 4, 2020

People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. And as long as the healthcare provider in charge judges the infusion therapy to be ethical and not violative of safety standards, they may prescribe it accordingly.

Therapy 89

Therapy Legalization Chronic Pain DEA 89

Cannabis Law Report

SEPTEMBER 23, 2019

The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. The AAFP recognizes the benefits of intervention and treatment for the recreational use of marijuana, in lieu of incarceration, for all individuals, including youth.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

JULY 1, 2021

In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency recognized psilocybin as a breakthrough therapy for treatment-resistant depression. These designations indicate that psychedelics may represent substantial improvements over existing treatments for mental health conditions.

Law 105

Law Research and Development Therapy DEA 105

Canna Law Blog

MARCH 4, 2020

People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. And as long as the healthcare provider in charge judges the infusion therapy to be ethical and not violative of safety standards, they may prescribe it accordingly.

Legalization 52

Legalization Therapy Chronic Pain DEA 52

Cannabis Law Report

MAY 17, 2019

Seq (1970) and Drug Enforcement Administration’s (“DEA”) clutches, 2019 hemp production and sales exploded. A wildly popular nutritional supplement and food additive, oil based hemp derived products like CBD racked up $1.1 Farm Bill’s Impact and Rise of the FDA. Beyond removing plant cannabis sativa L. Budgeted at $6.1

Food 10

Food DEA Hemp CBD 10

Cannabis Law Report

APRIL 13, 2022

market presence, complementary client programming and respected clinical research capabilities allow us to accelerate our strategic growth plans and broaden access to healing and wellness.” Clinics will also offer family and couples counselling, as well as in-person and virtual group therapy for expanded access to innovative treatments.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Later that year, Doblin sued the DEA for the first time. The first medical marijuana bills were passed in California and Arizona.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

MAY 24, 2022

Substances considered to pose the greatest risk to the public health and safety are subject to the most stringent controls and sanctions. In 2011, the DEA again dismissed a petition, claiming a lack of accessible studies especially on smoked marijuana in the United States.

DEA 52

DEA History Medicine Marijuana 52

The Cannigma

SEPTEMBER 12, 2021

This contradiction, combined with a problematic regulatory framework that limits access to THC products in many states, has created a booming market for d-8 and d-10. The safety of using these products however, is still unknown. The first researcher who identified and isolated THC, was the American Roger Adams (Shutterstock).

THC 98

THC Research and Development Cannabinoids CBD 98

The Cannigma

MAY 15, 2023

Ketamine has a long safety record as an anesthetic since the 1980s, and it has also been successfully used “off-label” for over a decade to treat conditions such as anxiety, depression, OCD, and PTSD, among others. Patients may want to seek assistance from a certified professional prior to embarking on treatment.

Therapy 78

Therapy Access Blood Pressure Treatment 78

The Cannigma

MAY 6, 2021

Other than serving as a lighter version of delta-9-THC, delta-8 has also been researched as a potential treatment for a number of medical conditions and symptoms such as vomiting and nausea, glaucoma, pain, and inflammation. When it comes to safety, the two main factors to consider are production (standards and regulation) and research.

THC 145

THC Cannabinoids Concentrates Hemp 145

Veriheal

FEBRUARY 23, 2024

As the Drug Enforcement Administration (DEA) and federal government draw closer to moving cannabis from a Schedule I to a Schedule III substance , more groups have begun to put their weight behind the movement. Countless veterans suffer from these ailments, and, as such, are pushing for access to as many treatments and therapies as possible.

DEA 102

DEA Chronic Pain Treatment Therapy 102

Canna Law Blog

NOVEMBER 16, 2021

The enforcement role moves from DEA to ATF. When it comes to enforcing federal cannabis regulations, the Drug Enforcement Administration (“DEA”) is out and the Bureau of Alcohol, Tobacco, Firearms, and Explosives (“ATF”) is in (in addition to TTB as the primary overseer). . International law and treaties.

DEA 88

DEA Business Banking Food 88

Cannabis Law Report

JULY 14, 2021

“Closing the door on broadly supported incremental reforms like the SAFE Banking Act while the Senate seeks compromise on farther-reaching bills hurts the possibilities for consensus and ignores the very real needs of small business operators who have repeatedly said that access to banking services and traditional lending is an existential issue.

Legislation 71

Legislation Banking History Access 71

Cannabis Law Report

JANUARY 14, 2020

CLICK IMAGE TO ACCESS COMMITTEE INFO PAGE. Additionally, it would open up medical marijuana policies with “directives to conduct research on the impact of marijuana on the brain, the efficacy of medical marijuana, identification of additional medical benefits and uses of cannabis, and support highway safety research.”. Legislation.

Clinical Trials 69

Clinical Trials Programs Access DEA 69